Cannabis Bioscience International Holdings (CBIH) Invested Capital (2022 - 2026)

Cannabis Bioscience International Holdings has disclosed Invested Capital across 5 years of filings, most recently posting -$1.5 million for Q1 2026.

• Invested Capital for Q1 2026 came in at -$1.5 million, down 26.05% year-over-year; the trailing twelve-month figure through Feb 2026 was -$1.5 million (down 26.05% YoY), and the FY2025 annual result was -$1.1 million, down 6.49% from the prior year.
• Invested Capital came in at -$1.5 million for Q1 2026 at Cannabis Bioscience International Holdings, down from -$1.3 million in the prior quarter.
• In the past five years, Invested Capital ranged from a high of -$405301.0 in Q4 2022 to a low of -$1.5 million in Q1 2026.
• The 5-year median for Invested Capital is -$1.1 million (2024), against an average of -$969755.4.
• Across the five-year window, Invested Capital plunged 104.74% in 2023 and decreased 6.49% in 2025, its largest moves.
• Cannabis Bioscience International Holdings' Invested Capital stood at -$405301.0 in 2022, then plunged by 104.74% to -$829807.0 in 2023, then slumped by 35.0% to -$1.1 million in 2024, then retreated by 20.38% to -$1.3 million in 2025, then fell by 7.71% to -$1.5 million in 2026.
• The last three Invested Capital figures came in at -$1.5 million (Q1 2026), -$1.3 million (Q4 2025), and -$1.2 million (Q3 2025), per Business Quant data.